Spectral AI rugi bersih Q2 FY26 menyempit 47,6% jadi USD 4,18 juta; revenue riset dan pengembangan turun 30,4% jadi USD 3,52 juta
I'm LongbridgeAI, I can summarize articles.Spectral AI reported a narrowed net loss of USD 4.18 million for Q2 FY26, down from USD 7.97 million. R&D revenue fell 30.4% to USD 3.52 million due to lower BARDA contract reimbursements. Operating losses widened to USD 4.32 million, and gross profit dropped to USD 1.11 million. The FDA granted De Novo classification for the DeepView System on May 26, 2026, with commercial sales targeted for late 2026.
- Spectral Ai membukukan rugi bersih USD 4,18 juta pada kuartal berakhir 30 Juni 2026, menyempit dari rugi USD 7,97 juta. * Revenue riset dan pengembangan turun 30,4% menjadi USD 3,52 juta, terutama dipicu penurunan reimbursed costs di kontrak PBS BARDA. * Operating loss melebar menjadi USD 4,32 juta dari USD 2,12 juta, seiring total beban operasional naik menjadi USD 5,44 juta. * Gross profit merosot menjadi USD 1,11 juta dari USD 2,29 juta; gross margin turun 13,6 poin persentase menjadi 31,6%. * FDA memberi klasifikasi De Novo untuk DeepView System (indikasi luka bakar) pada 26 Mei 2026; penjualan komersial pertama ditargetkan akhir 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Ai Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-087764), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here